Home/Filings/4/0001829813-25-000010
4//SEC Filing

MACDONALD LAURA ANN 4

Accession 0001829813-25-000010

CIK 0000851205other

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 4:35 PM ET

Size

34.8 KB

Accession

0001829813-25-000010

Insider Transaction Report

Form 4
Period: 2025-02-20
Transactions
  • Exercise/Conversion

    Restricted Stock Unit

    2025-02-211,6522,754 total
    Exercise: $0.00From: 2024-02-21Exp: 2026-02-21Common Stock (1,652 underlying)
  • Tax Payment

    Common Stock

    2025-02-20$33.40/sh440$14,6964,593 total
  • Tax Payment

    Common Stock

    2025-02-22$32.78/sh658$21,5697,086 total
  • Exercise/Conversion

    Restricted Stock Unit

    2025-02-222,0720 total
    Exercise: $0.00From: 2023-02-22Exp: 2025-02-22Common Stock (2,072 underlying)
  • Exercise/Conversion

    Common Stock

    2025-02-20+1,2685,033 total
  • Exercise/Conversion

    Common Stock

    2025-02-21+1,6526,245 total
  • Tax Payment

    Common Stock

    2025-02-21$32.78/sh573$18,7835,672 total
  • Exercise/Conversion

    Common Stock

    2025-02-22+2,0727,744 total
  • Exercise/Conversion

    Restricted Stock Unit

    2025-02-201,2685,071 total
    Exercise: $0.00From: 2025-02-20Exp: 2027-02-20Common Stock (1,268 underlying)
Holdings
  • Non-Qualified Stock Option (right to buy)

    Exercise: $48.28From: 2022-05-01Exp: 2029-05-01Common Stock (10,000 underlying)
    10,000
  • Non-Qualified Stock Option (right to buy)

    Exercise: $64.43From: 2023-02-22Exp: 2032-02-22Common Stock (23,891 underlying)
    23,891
  • Restricted Stock Unit

    Exercise: $0.00From: 2025-03-15Exp: 2027-03-15Common Stock (1,228 underlying)
    1,228
  • Non-Qualified Stock Option (right to buy)

    Exercise: $38.39From: 2018-02-21Exp: 2027-02-21Common Stock (12,500 underlying)
    12,500
  • Non-Qualified Stock Option (right to buy)

    Exercise: $33.04From: 2026-02-18Exp: 2035-02-18Common Stock (33,168 underlying)
    33,168
  • Non-Qualified Stock Option (right to buy)

    Exercise: $39.44From: 2025-02-20Exp: 2034-02-20Common Stock (37,698 underlying)
    37,698
  • Non-Qualified Stock Option (right to buy)

    Exercise: $50.94From: 2021-02-18Exp: 2030-02-18Common Stock (42,500 underlying)
    42,500
  • Non-Qualified Stock Option (right to buy)

    Exercise: $47.21From: 2024-02-21Exp: 2033-02-21Common Stock (30,492 underlying)
    30,492
  • Common Stock

    (indirect: By Children)
    20
  • Non-Qualified Stock Option (right to buy)

    Exercise: $56.44From: 2019-02-20Exp: 2028-02-20Common Stock (15,000 underlying)
    15,000
  • Non-Qualified Stock Option (right to buy)

    Exercise: $90.50From: 2022-02-16Exp: 2031-02-16Common Stock (13,946 underlying)
    13,946
  • Restricted Stock Unit

    Exercise: $0.00From: 2026-02-18Exp: 2028-02-18Common Stock (12,107 underlying)
    12,107
  • Non-Qualified Stock Option (right to buy)

    Exercise: $51.49From: 2020-02-19Exp: 2029-02-19Common Stock (30,000 underlying)
    30,000
Footnotes (8)
  • [F1]This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on February 20, 2025 and are reported herein.
  • [F2]This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on February 21, 2025 and are reported herein.
  • [F3]This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on February 22, 2025 and are reported herein.
  • [F4]Held by reporting person's child. The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.
  • [F5]Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.
  • [F6]The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 22, 2022), respectively.
  • [F7]The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 21, 2023), respectively.
  • [F8]The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 20, 2024), respectively.

Issuer

COGNEX CORP

CIK 0000851205

Entity typeother

Related Parties

1
  • filerCIK 0001773704

Filing Metadata

Form type
4
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 4:35 PM ET
Size
34.8 KB